CorMatrix Cor TRICUSPID ECM Valve Replacement Study
NCT02397668
This study is recruiting at 4 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The Pivotal Study of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve). This study follows the EFS and is now to determine the safety and efficacy of the Cormatrix Cor TRICUSPID Valve for any patients requiring surgical replacement of the tricuspid valve.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Tricuspid Valve Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 1 year to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Corvivo Cardiovascular, Inc.
- Last updated on ClinicalTrials.gov
- September 2, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- Springhill Memorial Hospital · Mobile, AL
Indiana · 1
- St Francis Hospital · Indianapolis, IN
Maryland · 1
- Medstar · Baltimore, MD
Ohio · 1
- Cincinnati Children's Hospital · Cincinnati, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.